Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection
Kevin Kwei(Stanford University), Robert J. Pelham(Genomic Health (United States))
Cited by 48
Related Papers
SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer
|PLoS ONE|2011|49